Known targets — ChEMBL curated mechanism
ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR3 | O14843 | 2/20 | 0.54 |
| ▸ | LCK | P06239 | 1/20 | 0.54 |
| ▸ | FYN | P06241 | 1/20 | 0.54 |
| ▸ | GLRA1 | P23415 | 1/20 | 0.44 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.44 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.44 |
| ▸ | GABRR1 | P24046 | 3/20 | 0.41 |
| ▸ | PAOX | Q6QHF9 | 3/20 | 0.41 |
| ▸ | LMNA | P02545 | 5/20 | 0.40 |
| ▸ | BLM | P54132 | 3/20 | 0.40 |
| ▸ | THRB | P10828 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | GABRR3 | A8MPY1 | 1/20 | 0.40 |
| ▸ | GABRP | O00591 | 1/20 | 0.40 |
| ▸ | GABRD | O14764 | 1/20 | 0.40 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.40 |
| ▸ | GABBR2 | O75899 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL8212315 | 1.00 | FFAR3 (0.54) | FFAR3LCKFYNGLRA1SLC6A9 | |
| Acetic Acid SCHEMBL65518 | 1.00 | FFAR3 (0.54) | FFAR3LCKFYNGLRA1SLC6A9 | |
| Acetic Acid SCHEMBL9138200 | 1.00 | FFAR3 (0.54) | FFAR3LCKFYNGLRA1SLC6A9 | |
| Acetic Acid SCHEMBL4433464 | 0.96 | FFAR3 (0.50) | FFAR3LCKFYNGLRA1SLC6A9 | |
| Acetic Acid SCHEMBL11682870 | 0.96 | FFAR3 (0.50) | FFAR3LCKFYNGLRA1SLC6A9 | |
| Acetic Acid SCHEMBL2864460 | 0.96 | FFAR3 (0.50) | FFAR3LCKFYNGLRA1SLC6A9 | |
| Acetic Acid SCHEMBL3009304 | 0.96 | FFAR3 (0.50) | FFAR3LCKFYNGLRA1SLC6A9 | |
| Acetic Acid SCHEMBL7704464 | 0.96 | FFAR3 (0.50) | FFAR3LCKFYNGLRA1SLC6A9 | |
| Acetic Acid SCHEMBL270502 | 0.96 | FFAR3 (0.50) | FFAR3LCKFYNGLRA1SLC6A9 | |
| Acetic Acid SCHEMBL6374681 | 0.96 | FFAR3 (0.50) | FFAR3LCKFYNGLRA1SLC6A9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 383 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120189371-A | Intelligent response skin care composition and preparation method and application thereof | 广州优理氏生物科技有限公司 | 2025-06-24 | — | — | CN | claimed |
| CN-119968205-A | Oral polypeptide composition and application thereof | 合肥天汇生物科技有限公司 | 2025-05-09 | — | — | CN | claimed |
| CN-119833190-A | Preparation method of low-temperature-resistant radioactive decontamination barreled wet tissue | 核工业北京化工冶金研究院 | 2025-04-15 | — | — | CN | claimed |
| CN-115078736-B | Homogeneous phase immunoassay kit for Alzheimer's disease | 佛山市观迪医疗器械有限公司 | 2025-03-25 | — | — | CN | claimed |
| CN-119613625-A | Branched polymer for selectively controlling water in oil well and preparation method thereof | 中国石油大学(华东) | 2025-03-14 | — | — | CN | claimed |
| CN-119371652-A | Method for preparing polyphenyl ether | 上海优铖工逸技术有限公司 | 2025-01-28 | — | — | CN | claimed |
| CN-118652422-A | High-purity high-temperature-resistant anti-aging low-dielectric polyphenyl ether and preparation method thereof | 四川大学 | 2024-09-17 | — | — | CN | claimed |
| CN-115089509-B | Essence and mask | 科丝曼(广州)有限公司 | 2024-06-25 | — | — | CN | claimed |
| CN-118078647-A | Double-layer sun-proof emulsion and preparation method thereof | 苏州绿叶日用品有限公司 | 2024-05-28 | — | — | CN | claimed |
| CN-116041703-B | High-whiteness low-impurity-content polyarylether and preparation method thereof | 四川大学 | 2024-05-24 | — | — | CN | claimed |
| US-20210212947-A1 | Docetaxel palmitate liposome and preparation method thereof | SHANGHAI WEI ER BIOPHARMACEUTICAL TECH CO., LTD. (CN) | 2021-07-15 | — | — | US | claimed |
| CN-112851931-A | Corrosion-resistant polyarylether resin, corrosion-resistant separation membrane and preparation method thereof | 四川大学 | 2021-05-28 | — | — | CN | claimed |
| CN-111569680-B | Polyarylether ultrafiltration membrane, nanofiltration membrane, preparation method and method for reversible conversion of ultrafiltration membrane and nanofiltration membrane | 四川大学 | 2021-03-19 | — | — | CN | claimed |
| CN-107982070-B | Whitening and moisturizing facial mask containing pomegranate essence and preparation method thereof | 上海晓美生物科技有限公司 | 2020-12-29 | — | — | CN | claimed |
| CN-108042425-B | Whitening and moisturizing essence and preparation method thereof | 上海晓美生物科技有限公司 | 2020-12-22 | — | — | CN | claimed |
| CN-111569680-A | Polyarylether ultrafiltration membrane, nanofiltration membrane, preparation method and method for reversible conversion of ultrafiltration membrane and nanofiltration membrane | 四川大学 | 2020-08-25 | — | — | CN | claimed |
| CN-110724263-B | Boron-containing two-dimensional polyarylene sulfide material with neutron absorption function and preparation method thereof | 四川大学 | 2020-08-14 | — | — | CN | claimed |
| CN-111100286-A | Green high-purity polyarylether and preparation method thereof | 成都锦颜科技有限公司 | 2020-05-05 | — | — | CN | claimed |
| US-20170304187-A1 | EMU Oil In Combination With Other Active Ingredients For Treating Skin Imperfections | DESAI, KETAN | 2017-10-26 | — | — | US | claimed |
| US-4406812-A | HYDROGEN PEROXIDE OR ADDITION COMPOUND WITH ALKALI METAL BORATE, CARBONATE OR PYROPHOSPHATE OR UREA | CHEMED CORPORATION (US) | 1983-09-27 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210212947-A1 | Docetaxel palmitate liposome and preparation method thereof | CETP, DLST, LIPA | FFAR3 272/4885LCK 3245/4885FYN 4201/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.